Positron Emission Tomograph(PET) Imaging Explores the Role of SF-DEVD-2 in Monitoring Tumor Efficacy
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Clinical Trials Related to Solid Tumor
Related studies linked through entity extraction aliases.
A Study of OMX-0407 in Patients With Previously Treated Solid Tumours That Can't be Removed Surgically
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
JYB1907 in Subjects With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Autologous Tumour Vaccine Trial
- Status
- RECRUITING
- Phase
- PHASE1
A Study of BL-B01D1 in Patients With Multiple Solid Tumors, Including Recurrent or Metastatic Gynecological Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Treatment of Advanced Solid Tumors With Neo-T(GI-NeoT-02)
- Status
- UNKNOWN
- Phase
- PHASE1
Neo-T in Treating Patients With Advanced Solid Tumors(GI-NeoT-03)
- Status
- UNKNOWN
- Phase
- PHASE1
A Phase 1 Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of EU103 in Advanced or Metastatic Solid Tumors That Have Failed Standard Therapy
- Status
- RECRUITING
- Phase
- PHASE1
Immunity to Infection in Healthy Participants and Participants With Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of BL-B01D1 in Patients With Multiple Solid Tumors, Including Locally Advanced or Metastatic Urinary System Tumors
- Status
- RECRUITING
- Phase
- PHASE2
Study of TU2218 in Combination With KEYTRUDA®(Pembrolizumab) in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
UCLM802 (Anti-Mesothelin CAR-T) Cell Injection in Patients With Mesothelin-positive Advanced Malignant Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Neoantigen Derived DCs as Cancer Treatment
- Status
- RECRUITING
- Phase
- PHASE1
A Phase I Study of Hemay181 in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Study of RD14-01 in Patients With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Clinical Study on the Safety and Efficacy of Chimeric Antigen Receptor T-cell (CART) in the Treatment of Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- NA
A Phase 1b/2, Multi-center, Single Arm Study to Assess the Safety and Efficacy of Neoantigen Synthetic Long Peptide Vaccines in Patients With Local Or Metastatic Solid Tumors
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE1/PHASE2
Study of MRTX1133 in Patients With Advanced Solid Tumors Harboring a KRAS G12D Mutation
- Status
- TERMINATED
- Phase
- PHASE1
A Study to Evaluate the Safety and Efficacy of A2B530, a Logic-gated CAR T, in Participants With Solid Tumors That Express CEA and Have Lost HLA-A*02 Expression
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2